Exosome therapy, a regenerative medicine, has dermatologists and plastic surgeons rethinking the future of aesthetics, and ...

Medicine to treat sexually transmitted gonorrhoea is in the late stages of trials. In a recent study published by The Lancet, ...

The biotechnology company said its Bria-IMT plus check point inhibitors showed a 17.3-month survival rate for patients with hormone receptor-positive breast cancer, exceeding the 14.4 months of ...

European regulators have finally approved the Alzheimer's treatment Leqembi after an advisory committee initially rejected the drug last summer and then reconsidered it.

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain has developed a drug candidate that could help fight the condition at its ...

A new oral antibiotic, gepotidacin, may treat gonorrhea. The gepotidacin FDA approval may help this drug reach those who need it.

Cambridge found a drug that costs mere pennies per pill could help prevent a type of cancer that kills about four out of five ...

Pharma companies are leveraging the United States’ threat of tariffs on drug imports to push for policy changes in the EU. | Pharma companies are leveraging the Trump administration’s threat of ...

Methamphetamine is New Zealand's most harmful illicit drug and wastewater testing shows its use and availability are on the ...

Pharmaceutical pollution in waterways is changing animal behavior. Exposure to an antianxiety drug is affecting migrating Atlantic salmon, according to a new study.

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.